{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:41:29Z","timestamp":1790386889635,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.autrev.2023.103356","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:48:02Z","timestamp":1683323282000},"page":"103356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value"],"prefix":"10.1016","volume":"22","author":[{"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdanos","family":"Dimitrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Ielo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.autrev.2023.103356_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2023.103356_bb0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/acr.23712","article-title":"Antinuclear antibody-negative systemic lupus erythematosus in an international inception cohort","volume":"71","author":"Choi","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.autrev.2023.103356_bb0015","doi-asserted-by":"crossref","first-page":"103138","DOI":"10.1016\/j.autrev.2022.103138","article-title":"Are IF-ANA the guiding light for SLE classification in the real-world setting?","volume":"21","author":"Gualtierotti","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2023.103356_bb0020","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2022-222168","article-title":"Longitudinal analysis of ANA in the systemic lupus international collaborating clinics (SLICC) inception cohort","volume":"81","author":"Choi","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2023.103356_bb0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","article-title":"Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases","volume":"16","author":"Bossuyt","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103356_bb0030","article-title":"Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus","volume":"5","author":"Infantino","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2023.103356_bb0035","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0961203310362995","article-title":"Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test","volume":"19","author":"Antico","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103356_bb0040","article-title":"Comparison of current methods for anti-dsDNA antibody detection and reshaping diagnostic strategies","volume":"29","author":"Infantino","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2023.103356_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808008","article-title":"The anti-DNA antibodies: their specificities for unique DNA structures and their unresolved clinical impact\u2014a system criticism and a hypothesis","volume":"12","author":"Rekvig","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103356_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103356_bb0055","series-title":"Classification Criteria: World Premiere and Real-World Applications. Oral Presentation at ACR22","author":"Erkan","year":"2023"},{"key":"10.1016\/j.autrev.2023.103356_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726820","article-title":"Antiphospholipid antibody assays in 2021: looking for a predictive value in addition to a diagnostic one","volume":"12","author":"Meroni","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103356_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2018.198119","article-title":"New insight into antiphospholipid syndrome: antibodies to \u03b22glycoprotein I-domain 5 fail to induce thrombi in rats","volume":"104","author":"Urigutto","year":"2019","journal-title":"Haematologica."},{"key":"10.1016\/j.autrev.2023.103356_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103356_bb0075","unstructured":"Grossi et al. Submitted."},{"issue":"1","key":"10.1016\/j.autrev.2023.103356_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2018.07.006","article-title":"Connective tissue disease: current concepts","volume":"37","author":"Fernandez","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.autrev.2023.103356_bb0085","series-title":"Autoantibodies associated with connective tissue diseases: What meaning for clinicians?","volume":"vol. 9","author":"Didier","year":"2018"},{"issue":"8","key":"10.1016\/j.autrev.2023.103356_bb0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","article-title":"Systemic lupus erythematosus one disease or many?","volume":"11","author":"Agmon-Levin","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2023.103356_bb0095","first-page":"831","article-title":"Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis","volume":"7","author":"Lom-Orta","year":"1980","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103356_bb0100","first-page":"213","article-title":"Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both?","volume":"32","author":"Doria","year":"2005","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103356_bb0105","first-page":"471","article-title":"Analysis of the evolution of UCTD to defined CTD after a long term follow-up","volume":"31","author":"Mosca","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"16","key":"10.1016\/j.autrev.2023.103356_bb0110","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2023.103356_bb0115","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1515\/cclm-2017-0241","article-title":"Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies","volume":"56","author":"P\u00e9rez","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103356_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102506","article-title":"Precision medicine in the care of rheumatoid arthritis: focus on prediction and prevention of future clinically-apparent disease","volume":"19","author":"Mahler","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"NOV","key":"10.1016\/j.autrev.2023.103356_bb0125","article-title":"The utilization of autoantibodies in approaches to precision health","volume":"9","author":"Fritzler","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103356_bb0130","series-title":"Biomarkers in connective tissue diseases","first-page":"1473","volume":"vol. 140","author":"Jog","year":"2017"},{"issue":"11","key":"10.1016\/j.autrev.2023.103356_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/gtmb.2019.0064","article-title":"Diagnostics of hereditary connective tissue disorders by genetic next-generation sequencing","volume":"23","author":"Pope","year":"2019","journal-title":"Genet Test Mol Biomarkers"},{"issue":"10","key":"10.1016\/j.autrev.2023.103356_bb0140","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2023.103356_bb0145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-022-01880-6","article-title":"The promise of precision medicine in rheumatology","volume":"28","author":"Guthridge","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.autrev.2023.103356_bb0150","first-page":"1332","article-title":"Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease","volume":"18","author":"Alarc\u00f3n","year":"1991","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103356_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103298","article-title":"Identifying subsets of patients with undifferentiated connective tissue disease: results from a prospective, real-world experience using particle-based multi-analyte technology","volume":"22","author":"Radin","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103356_bb0160","article-title":"Impact of autoimmune serology test results on RA classification and diagnosis","volume":"5","author":"Van Hoovels","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2023.103356_bb0165","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103356_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2013-203284","article-title":"Performance of the 2010 ACR\/EULAR classification criteria for rheumatoid arthritis: a systematic literature review","volume":"73","author":"Radner","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103356_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002099","article-title":"Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein\/peptide antibodies test results","volume":"8","author":"Van Hoovels","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2023.103356_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2017-212365","article-title":"Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR\/EULAR classification of rheumatoid arthritis","volume":"77","author":"Van Hoovels","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103356_bb0185","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"issue":"9842","key":"10.1016\/j.autrev.2023.103356_bb0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103356_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440665","article-title":"Interstitial lung disease evaluation: detecting connective tissue disease","volume":"90","author":"Fischer","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2023.103356_bb0200","doi-asserted-by":"crossref","first-page":"e000827","DOI":"10.1136\/bmjresp-2020-000827","article-title":"Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts","volume":"8","author":"Machahua","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"12","key":"10.1016\/j.autrev.2023.103356_bb0205","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1177\/09612033221122158","article-title":"Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and\/or myositis","volume":"31","author":"Cotton","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103356_bb0210","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MCP.0b013e328363f48d","article-title":"Update on the diagnosis and classification of ILD","volume":"19","author":"Ryerson","year":"2013","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"10.1016\/j.autrev.2023.103356_bb0215","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103356_bb0220","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2023.103356_bb0225","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00408-018-0108-8","article-title":"Prevalence of myositis-specific antibodies in idiopathic interstitial pneumonias","volume":"196","author":"De Sadeleer","year":"2018","journal-title":"Lung"},{"issue":"21","key":"10.1016\/j.autrev.2023.103356_bb0230","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3748\/wjg.v28.i21.2291","article-title":"Serological biomarkers for management of primary sclerosing cholangitis","volume":"28","author":"Tornai","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103356_bb0235","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/apt.16201","article-title":"Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?","volume":"53","author":"Tornai","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.autrev.2023.103356_bb0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103356_bb0245","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver","year":"2022","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103356_bb0250","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","article-title":"Cholestatic liver disease: current treatment strategies and new therapeutic agents","volume":"81","author":"Hasegawa","year":"2021","journal-title":"Drugs."},{"key":"10.1016\/j.autrev.2023.103356_bb0255","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2023.103356_bb0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103356_bb0265","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","article-title":"Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis","volume":"58","author":"Villalta","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2023.103356_bb0270","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103356_bb0275","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2023.103356_bb0280","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3389\/fimmu.2019.00662","article-title":"The prevalence of anti-Hexokinase-1 and anti-Kelch-like 12 peptide antibodies in patients with primary biliary cholangitis is similar in Europe and North America: a large international, multi-center study","volume":"10","author":"Norman","year":"2019","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:28:29Z","timestamp":1761600509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1568997223000903"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103356","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103356"}}